Month: July 2024

On 4 March 2024, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 13 of 1 March 2024. Under the programme, Schouw & Co. will acquire shares for up to DKK 200 million during the period 4 March 2024 to 31 December 2024. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount    Accumulated until 28/6/2024 140,500 543.47 76,357,900    Monday, 1 July 2024 1,900 550.28 1,045,532    Tuesday, 2 July 2024 1,800 554.46 998,028    Wednesday, 3 July 2024 1,700 559.47 951,099    Thursday, 4 July 2024 1,600 564.84 903,744    Friday,...

Publication of data relating to RenovoRx’s targeted therapy platform to treatment of Locally Advanced Pancreatic Cancer (LAPC) is expected to be in the Summer 2024 issue of a prestigious journal LOS ALTOS, Calif., July 08, 2024 (GLOBE NEWSWIRE) — RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced acceptance for publication in an international peer-reviewed journal, The Oncologist. The manuscript is titled, “Treatment of Locally Advanced Pancreatic Cancer (LAPC) Using Localized Trans-Arterial Micro Perfusion (TAMP™) of Gemcitabine: Combined Analysis of RR1 and RR2” and expected in the Summer 2024 issue of The Oncologist The manuscript’s lead author is Hassan Hatoum, MD,...

3D Systems’ DMP Flex 350 Dual3D Systems’ DMP Flex 350 platform is designed for flexible application use from application development to serial production.Collaboration intended to catalyze metal AM applications in high-criticality markets Precision Resource integrating two 3D Systems DMP Flex 350 Dual printers into manufacturing workflow to support efforts DMP Flex 350’s best-in-class environmental control, inert atmosphere ensures exceptionally high-quality parts for precision applicationsROCK HILL, S.C. and SHELTON, Conn., July 08, 2024 (GLOBE NEWSWIRE) — Today, 3D Systems (NYSE:DDD), a leading additive manufacturing solutions provider, and Precision Resource, a leader in the production of critical components for the automotive, heavy-duty, aerospace, and medical device industries, announced they have entered...

On 22 March 2024, Pro Kapital entered into a share purchase agreement to acquire a 67.5% stake in Preatoni Nuda Proprieta S.R.L. (registered in Milan, Italy). Pursuant to the terms and conditions of the senior secured callable fixed rate bonds 2020/2028 with ISIN SE0013801172, with a total nominal amount outstanding of EUR 19,950,000, issued by Pro Kapital, Pro Kapital is obliged to pledge all of Pro Kapital’s shares of the acquired company in favour of the agent Nordic Trustee & Agency AB and all the bondholders (represented by Nordic Trustee & Agency AB) after the completion of the above mentioned share purchase. Pro Kapital announces that it has entered into the required notarial deed of pledge in Italy on 5 July 2024 in respect of 67.5% of the shares in Preatoni Nuda Proprieta S.R.L. and the Italian notary submitted the relevant...

CHANTILLY, Va., July 08, 2024 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) will release second quarter 2024 financial results before the markets open on Wednesday, July 31, 2024. The company will host a conference call at 8:00 a.m. Eastern Time that day to discuss its earnings results and strategic corporate initiatives. Access to a webcast of the live conference call can be obtained through the Investor Relations section of the company’s website (https://investors.parsons.com). Those parties interested in participating via telephone may register on the Investor Relations website or by clicking here. A replay will be available on the company’s website approximately two hours after the conference call and continuing for one year. About Parsons Corporation Parsons (NYSE: PSN) is a leading disruptive technology provider...

Toronto, July 08, 2024 (GLOBE NEWSWIRE) — Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”) an exploration company with a portfolio of properties in Northern Ontario and Santa Cruz, Argentina, is pleased to announce that it has signed a binding agreement of purchase and sale dated July 8, 2024 (the “Agreement”) with Rudolf Wahl and Mike Dorval (the “Wahl Group”) to acquire (the “Acquisition”) a 100% interest in forty-two (42) unpatented cell claims in Killala Lake Area Townships, Thunder Bay Mining District, in the Province of Ontario (the “Claims” or the ”Ruffle Lake Property”) The Ruffle Lake Property is readily accessible via an all-weather road 35 km north from the Trans Canada Highway 17. The Claims are contiguous to the Company’s Good Hope Niobium Project.‎Microsoft...

WATERTOWN, Mass., July 08, 2024 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that C4T management will participate in a fireside chat at the UBS Targeted Protein Degradation (TPD) Day taking place virtually on July 15, 2024. Fireside Chat Details:Event: UBS TPD DayDate/Time: Monday, July 15, 2024 from 12:00 pm ET – 12:30 pm ET A live webcast will be available on the Investors section of the company’s website at www.c4therapeutics.com. An archived replay of the webcast will be available for approximately 30 days following the live event. About C4 TherapeuticsC4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein...